Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results

Go back to Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results

Medpace Holdings (MEDP) Tops Q4 EPS by 49c, Beats on Revenue; Offers FY26 Revenue Guidance

February 9, 2026 4:17 PM EST

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $4.67, $0.49 better than the analyst estimate of $4.18. Revenue for the quarter came in at $708.5 million versus the consensus estimate of $689.34 million.

GUIDANCE:

Medpace Holdings sees FY2026 revenue of $2.76-2.86 billion, versus the consensus of... More